What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of study are Internal medicine, Colorectal cancer, Cancer, Odds ratio and Endocrinology.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.
His work in Oncology covers topics such as Microsatellite instability which are related to areas like KRAS.
The Colorectal cancer study combines topics in areas such as Epidemiology, Pathology, Bioinformatics and Lower risk, Confidence interval.
The study incorporates disciplines such as Relative risk, Prospective cohort study and Risk assessment in addition to Cancer.
The concepts of his Odds ratio study are interwoven with issues in Food group, Case-control study and Genetic association.
His most cited work include:
- Vegetables, Fruit, and Cancer Prevention: A Review (1919 citations)
- Food, nutrition and the prevention of cancer : a global perspective (1882 citations)
- Phases of Biomarker Development for Early Detection of Cancer (1256 citations)
What are the main themes of his work throughout his whole career to date?
John D. Potter mainly focuses on Internal medicine, Colorectal cancer, Cancer, Oncology and Odds ratio.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Genotype.
His Colorectal cancer study combines topics in areas such as Genome-wide association study, Single-nucleotide polymorphism, Epidemiology, Pathology and Microsatellite instability.
His biological study spans a wide range of topics, including Relative risk, Aspirin and Surgery.
John D. Potter has researched Oncology in several fields, including Lynch syndrome, Bioinformatics, Proportional hazards model, Prospective cohort study and Family history.
His studies in Odds ratio integrate themes in fields like Lower risk, Confidence interval, Mendelian randomization and Logistic regression.
He most often published in these fields:
- Internal medicine (80.44%)
- Colorectal cancer (64.36%)
- Cancer (42.84%)
What were the highlights of his more recent work (between 2013-2021)?
- Colorectal cancer (64.36%)
- Internal medicine (80.44%)
- Oncology (46.84%)
In recent papers he was focusing on the following fields of study:
Colorectal cancer, Internal medicine, Oncology, Cancer and Odds ratio are his primary areas of study.
His Colorectal cancer study incorporates themes from Aspirin, Genome-wide association study, Single-nucleotide polymorphism and Bioinformatics.
Much of his study explores Internal medicine relationship to Gastroenterology.
His research in Oncology intersects with topics in Logistic regression, Epidemiology, Microsatellite instability, Disease and Risk factor.
The Cancer study which covers Genetic predisposition that intersects with Absolute risk reduction.
His studies deal with areas such as Mendelian randomization, Adenoma, Mendelian Randomization Analysis, Confidence interval and Confounding as well as Odds ratio.
Between 2013 and 2021, his most popular works were:
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents (887 citations)
- Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival (250 citations)
- Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival (250 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His primary scientific interests are in Colorectal cancer, Internal medicine, Oncology, Cancer and Hazard ratio.
His Colorectal cancer study incorporates themes from Genome-wide association study, Bioinformatics, Case-control study, Pathology and Confidence interval.
His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with problems in Lower risk.
His research in Oncology intersects with topics in Proportional hazards model, Surgery, Logistic regression and Microsatellite instability.
His study in Cancer is interdisciplinary in nature, drawing from both MUTYH, Incidence and Immunohistochemistry.
His studies in Hazard ratio integrate themes in fields like Tobacco control, Prospective cohort study, Gynecology and Lung cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
